Service Hotline :
400-115-9001 400-115-9001
ECMO equipment introduction and clinical trial design ideas
Medical Devices
Jul. 26th, 2023
On January 4, 2023, the State Food and Drug Administration reviewed, emergency approval of Shenzhen Hanno Medical Technology Co., Ltd. in vitro cardiopulmonary support assistance equipment, disposable membrane oxygenator package registration application, as the first domestic ECMO equipment and consumables package, the product has independent intellect

  On January 4, 2023, the State Food and Drug Administration reviewed, emergency approval of Shenzhen Hanno Medical Technology Co., Ltd. in vitro cardiopulmonary support assistance equipment, disposable membrane oxygenator package registration application, as the first domestic ECMO equipment and consumables package, the product has independent intellectual property rights, performance indicators basically reached the international level of similar products.

 
ECMO, full name extracorporeal membrane oxygenation, Chinese name Extracorporeal membrane oxygenation, as an important extracorporeal life support technology, it is mainly used clinically to support cardiac and/or respiratory dysfunction. Compared with artificial heart-lung machine, ECMO has a longer duration (> 24h) cardiopulmonary bypass function, providing an important time window for the primary disease treatment of critically ill patients, deepening doctors' understanding of the primary disease treatment, and gaining time for the diagnosis and treatment of the primary disease.
 
Introduction to ECMO equipment
 
1, ECMO equipment classification code and management category
 
Refer to the Medical Device Classification Directory, ECMO devices belong to the subdirectory “ 10- Blood transfusion, dialysis and extracorporeal circulation devices” “ Level I Product Category 05- Cardiopulmonary Bypass Equipment” , specifically involving three secondary product categories:
 
(1) 10-05-01- Cardiopulmonary Bypass pump
 
(2) 10-05-02- Cardiopulmonary Bypass Monitoring Equipment
 
(3) 10-05-04- External cardiopulmonary Support Assistance System.
 
2, How it works:
 
Blood is drawn outside the patient's body using a catheter and pump system, in a gas exchanger, carbon dioxide is removed and oxygen is added. The oxygenated blood is then pumped back into the patient's circulatory system to maintain the oxygenated blood supply to the body's organs and tissues, which can help patients with cardiac arrest or not breathing to stay alive through the dangerous phase of the disease.
 
3. Healing mode:
 
According to the different ways of blood transfusion, it can be divided into: V-A mode, V-V mode, mixed mode.
 
(1) veno-venous ECMO (VV-ECMO) - Lung support
 
VV.png
 
(2) venous-arterial ECMO (VA-ECMO) - cardiopulmonary support
 
VA.png
 
(3) Mixed mode: VV-A, V-AV, VV-AV, VVV-A, etc.
 
4, structure composition
 
Centrifugal pump pump head, extracorporeal circulation pipeline, oxygenator, air oxygen mixer, filter, heat exchange water tank and other medical equipment, of which cardiopulmonary bypass pump is the core component of extracorporeal circulation equipment, according to the type of technology can be mainly divided into two categories: rolling pump and centrifugal pump. At present, the ECMO equipment that has been approved for market in China adopts centrifugal pump technology.
 
Note: The centrifugal pump head is a passive medical device, which needs to be registered separately and is not within the scope of application of the ECMO equipment registration review guidelines.
 
Guidelines for ECMO Device registration
 
 
Design ideas for ECMO clinical trials
 
1. Clinical trial protocol design method
 
ECMO clinical trials should use a prospective, multicenter design.
 
2. ECMO clinical inclusion criteria:
 
(1) No gender, age & ge; 18 years old;
 
(2) Agree to participate in this study and sign the informed consent;
 
(3) Subjects clinically judged to require ECMO life support (e.g., hypoxic respiratory failure, hypercapnia respiratory failure, lung transplant support, reversible cardiogenic shock).
 
3. ECMO clinical exclusion criteria:
 
(1) Patients with unrecoverable (irreversible) diseases, such as severe brain dysfunction, severe damage to the central nervous system, and severe multiple organ failure whose survival time is judged by the investigator to be < 24h;
 
(2) severe active bleeding or coagulation dysfunction (such as intracranial hemorrhage, gastrointestinal hemorrhage);
 
(3) Patients treated during pregnancy and lactation;
 
(4) Participants who have participated in other clinical trials within 1 month.
 
4. ECMO clinical evaluation indicators:
 
(1) Main evaluation index: the rate of traffic reaching the standard during 24h on the machine.
 
(2) Secondary evaluation indicators: the rate of traffic compliance at different on-machine time points, the monitoring situation of the detection system during on-machine, the performance evaluation of the instrument, the probability of successful withdrawal, etc.
 
5. Note that informed signing of ECMO requires a combination of approaches.
Previous:The CPSC has adopted ASTM F2057-23, a mandatory standard for protecting dressers and other clothing storage units from tipping
Next:What is EPD environmental product statement? Why do enterprises do EPD?
Back List
Related News
Hot News
Hot Tags
Consult Call